US › Healthcare

Cytosorbents Crp (CTSO)

US · Healthcare · Medical Devices

$5.76+0.52%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$9.6M

Revenue YoY

+0.2%

Net profit

$-4.4M

Profit YoY

-326.9%

EPS

$-0.07

EPS estimate

$-0.05

Net margin

-45.9%

EPS came in at -0.07 against a street estimate of -0.05 — a miss of 40.0%.

Key statistics

Market cap

$19.1M

Forward P/E

7.2

P/B

11.43

Book value

$-0.24

EPS (TTM)

$-5.94

52-week high

$7.44

52-week low

$0.30

50-day MA

$7.27

200-day MA

$11.10

Beta

1.34

Analyst view

Analysts rate Cytosorbents Crp a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $47.50.

Shareholding

Insiders

15.99%

Institutions

25.78%

Largest institutional holders

Fund	Stake
Avenir Corporation	8.30%
Vanguard Capital Management, LLC	2.99%
Neuberger Berman Group LLC	2.68%
CM Management, LLC	2.35%
Skylands Capital, LLC	1.93%
BlackRock Inc	1.25%
Geode Capital Management, LLC	1.13%
Sargent Investment Group, LLC	0.88%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cytosorbents Crp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.